A study published in the Journal of Translational Medicine has identified a mechanism by which the extracellular matrix protein elastin influences bone formation. The study, published on 10 November 2026, demonstrates that elastin-associated epigenetic regulation of the ROCK1/Wnt/β-catenin signaling pathway promotes osteogenesis in bone marrow-derived mesenchymal stem cells (BMSCs). This finding provides a mechanistic basis for using elastin peptides in biomaterials designed to enhance cranial bone regeneration, particularly in the context of osteoporosis.
Osteoporosis is a prevalent metabolic bone disorder characterized by progressive bone loss and increased fragility. While the elastin gene (ELN) has emerged as a potential regulator of BMSC osteogenic differentiation, its specific regulatory mechanisms remained incompletely understood prior to this investigation. The research team sought to elucidate the role of ELN in this process by combining transcriptomic screening with functional biomaterial evaluations.
To screen for osteogenesis-associated regulators during BMSC differentiation, the authors conducted single-cell transcriptomic analyses. The team then assessed the epigenetic function of ELN through chromatin remodeling and pathway activation analyses.
The results indicated that ELN expression increased during osteogenic differentiation, accompanied by enhanced nuclear enrichment of the elastin protein. Mechanistically, the study found that ELN-associated chromatin enrichment at ROCK1 regulatory regions was accompanied by increased ROCK1 expression. This upregulation was accompanied by activation of Wnt/β-catenin signaling, thereby promoting osteogenic differentiation. The data suggest that elastin acts as a pivotal epigenetic regulator, modulating the expression of ROCK1 to drive the osteogenic differentiation of BMSCs.
Building on these molecular findings, the researchers designed a functionalized silk fibroin (SF) hydrogel incorporating ELN peptides. This biomaterial was evaluated both in vitro for osteogenic induction and in vivo using an osteoporosis-related cranial defect model.
In vitro evaluations demonstrated that the ELN-functionalized SF hydrogel exhibited excellent biocompatibility and promoted the osteogenic differentiation of BMSCs.
In vivo experiments using an osteoporosis-related cranial defect model showed that the ELN-functionalized SF hydrogel effectively repaired cranial defects.
The study concludes that ELN is a pivotal epigenetic regulator of BMSC osteogenesis, acting through the ROCK1/Wnt/β-catenin axis. The incorporation of ELN peptides into a silk fibroin hydrogel provides a novel biomaterial-based strategy for enhancing bone regeneration.
Subject of Research: Epigenetic regulation of osteogenesis by elastin in silk fibroin hydrogels
Article Title: Elastin-associated epigenetic regulation of ROCK1/Wnt/β-catenin signaling promotes BMSC osteogenesis and cranial bone regeneration
Article References: Zhang, Y., Chuai, Y., Zhang, W., Feng, L., Liu, D., Sun, W., Hong, B., Wang, Q., Wang, Y., Luo, Z., Wang, X., & Zhang, H. (2026). Elastin-associated epigenetic regulation of ROCK1/Wnt/β-catenin signaling promotes BMSC osteogenesis and cranial bone regeneration. Journal of Translational Medicine. https://doi.org/10.1186/s12967-026-09190-y
Image Credits: AI Generated
DOI: 10.1186/s12967-026-09190-y
Keywords: osteoporosis, bone regeneration, elastin, silk fibroin, hydrogel, epigenetics, Wnt signaling, ROCK1, BMSC, tissue engineering, Elastin-associated, epigenetic
News Source: Ophelia Keating. (November 10, 2026). Elastin peptides in silk hydrogels aid cranial bone repair. Scienmag.



